DGIST Signs MOU with Bio Venture 'Wibrain' for Joint Research on Brain-Computer Technologies
DGIST (President Geonwoo Lee) announced on June 8 that it has signed a memorandum of understanding (MOU) with Wibrain (CEO Kiwon Lee) to develop next-generation BCI (Brain-Computer Interface) technologies and to strengthen research infrastructure in the fields of brain and neuroscience.
This agreement was established to expand the research and demonstration foundation of the domestic BCI industry and to secure global competitiveness in advanced national technology sectors. Wibrain, a leading company in electronic medicine technology in Korea, plans to expand its research scope into next-generation brain science and brain engineering technologies, including BCI, through this collaboration.
Lee Giwon, CEO of Ybrain (left), and Lee Gunwoo, President of DGIST, are holding up the signed memorandum of understanding after concluding the agreement.
View original imageTo generate tangible results from the agreement, the two organizations will pursue joint research and the securing of core technologies in the BCI field, the joint utilization of DGIST’s advanced research infrastructure and GMP (Good Manufacturing Practice) certified facilities in biomedical engineering, and the establishment of an industry-academia cooperation system to acquire globally leading technologies.
In particular, this collaboration is significant in that it combines DGIST’s technological expertise and convergent research infrastructure with Wibrain’s capabilities in medical device commercialization, thereby establishing a foundation for full-cycle cooperation from research and development to demonstration and commercialization of BCI technologies. BCI is a next-generation interface technology that interprets brain signals or stimulates the brain to connect external devices directly with the brain, and is regarded as a key technology with the potential to expand into a variety of future industries, including healthcare, rehabilitation, robotics, and artificial intelligence.
Furthermore, as the government is promoting BCI as one of the main missions of its "K-Moonshot" top-tier technology innovation project, both organizations intend to contribute to the development of national strategic technologies and to strengthen the domestic brain science and engineering ecosystem through this agreement.
DGIST President Geonwoo Lee stated, "Leveraging the world-class biomedical engineering research capabilities and advanced research infrastructure that DGIST has accumulated, this will be an opportunity to further strengthen the domestic foundation for BCI research," adding, "Through close collaboration with Wibrain, we will take the lead in securing next-generation top-tier technologies and building an advanced bio and brain science ecosystem."
Kiwon Lee, CEO of Wibrain, commented, "This collaboration with DGIST is an important turning point that goes beyond the growth of an individual company, as it combines DGIST’s advanced research infrastructure with private sector technology to broaden the horizons of Korea’s BCI industry," and added, "By contributing to the 'K-Moonshot' national strategic project and leading the establishment of global technology standards, we will do our utmost to position Korea at the center of the global brain science market."
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Meanwhile, DGIST plans to continue expanding its research infrastructure in future promising technology fields such as BCI, advanced biosciences, artificial intelligence, and robotics based on industry-academia research cooperation, and to pursue ongoing collaborations to secure national strategic technologies and enhance global research competitiveness.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.